Skip to main content
SpringerLink
Log in

Pathophysiology of Retinal Vein Occlusions

  • Chapter
  • First Online:
Retinal Vein Occlusions

Abstract

The pathophysiology of retinal vein occlusion (RVO) consists of the three components of Virchow’s triad – abnormalities of the vessel wall (considered in Chap. 1), alterations in the blood (e.g., abnormalities of viscosity and coagulation), and alterations in blood flow.1 This chapter addresses alterations of the blood and of blood flow.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    The astute reader will question how a typical critical closing value can be approximately 70 mmHg and yet approximately 7 mmHg less than SBP. SBP is usually quite a bit higher than 77 mmHg. The only thing I can think of is that the scleral suction cup gave the experimental subjects a bit of a vagal reaction. In any case, those numbers are what the paper states.

References

  1. Gutman FA. Evaluation of a patient with central retinal vein occlusion. Ophthalmology. 1983;90:481–3.

    PubMed  CAS  Google Scholar 

  2. Gariano RF, Kalina RE, Hendrickson AE. Normal and pathological mechanisms in retinal vascular development. Surv Ophthalmol. 1996;40:481–90.

    Article  PubMed  CAS  Google Scholar 

  3. Vine AK, Samama MM. The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions. Surv Ophthalmol. 1993;37:283–92.

    Article  PubMed  CAS  Google Scholar 

  4. Larsson J, Olafsdottir E, Bauer B. Activated protein C resistance in young adults with central retinal vein occlusion. Br J Ophthalmol. 1996;80:200–2.

    Article  PubMed  CAS  Google Scholar 

  5. Trope GE, Lowe GD, McArdle BM, et al. Abnormal blood viscosity and hemostasis in long-standing retinal vein occlusion. Br J Ophthalmol. 1983;67:137–42.

    Article  PubMed  CAS  Google Scholar 

  6. Lowenberg EC, Meijers JCM, Levi M. Platelet-vessel wall interaction in health and disease. Neth J Med. 2010;68:242–51.

    PubMed  CAS  Google Scholar 

  7. Dodson PM, Haynes J, Starczynski J, et al. The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion. Eye. 2003;17:772–7.

    Article  PubMed  CAS  Google Scholar 

  8. Coller BS. Seminars in medicine of the Beth Israel Hospital, Boston-platelets and thrombolytic therapy. N Engl J Med. 1990;322:33–42.

    Article  PubMed  CAS  Google Scholar 

  9. Kuhli C, Scharrer I, Koch F, et al. Factor XII deficiency: a thrombophilic risk factor for retinal vein occlusion. Am J Ophthalmol. 2004;137:459–64.

    Article  PubMed  CAS  Google Scholar 

  10. Elman MJ. Thrombolytic therapy for central retinal vein occlusion: results of a pilot study. Trans Am Ophthalmol Soc. 1996;94:471–504.

    PubMed  CAS  Google Scholar 

  11. Wu J, Zhou X, Hu Y, et al. Video microscope recording of the dynamic course of thrombosis and thrombolysis of the retinal vein in rabbits. Retina. 2010;30:966–70.

    Article  PubMed  Google Scholar 

  12. Ririe DG, Cosgriff TM, Martin B. Central retinal vein occlusion in a patient with familial antithrombin III deficiency: case report. Ann Ophthalmol. 1979;11:1841–5.

    PubMed  CAS  Google Scholar 

  13. Larsson J, Hillarp A, Olafsdottir E, Bauer B. Activated protein C resistance and anticoagulant proteins in young adults with central retinal vein occlusion. Acta Ophthalmol Scand. 1999;77:634–7.

    Article  PubMed  CAS  Google Scholar 

  14. Ma AD, Abrams CS. Activated protein C resistance, factor V Leiden and retinal vein occlusion. Retina. 1998;18:297–300.

    Article  PubMed  CAS  Google Scholar 

  15. Dahlback B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA. 1994;91:1396–400.

    Article  PubMed  CAS  Google Scholar 

  16. Loscalzo J, Braunwald E. Tissue plasminogen activator. N Engl J Med. 1988;319:925–31.

    Article  PubMed  CAS  Google Scholar 

  17. Ghazi NG, Noureddine BN, Haddad RS, et al. Intravitreal tissue plasminogen activator in the management of central retinal vein occlusion. Retina. 2003;23:780–4.

    Article  PubMed  Google Scholar 

  18. Wiechens B, Schroder JO, Potzsch B, Rochels R. Primary antiphospholipid antibody syndrome and retinal occlusive vasculopathy. Am J Ophthalmol. 1997;123:848–50.

    PubMed  CAS  Google Scholar 

  19. Noel LP, Botash AS, DeSilva A. Maternal antiphospholipid antibodies and vitreous hemorrhages in the newborn: a case report. Arch Ophthalmol. 2001;119:914–6.

    PubMed  CAS  Google Scholar 

  20. Iijima H, Gohdo T, Imai M, Tsukahara S. Thrombin-antithrombin III complex in acute retinal vein occlusion. Am J Ophthalmol. 1998;126:677–82.

    Article  PubMed  CAS  Google Scholar 

  21. Weger M, Renner W, Steinbrugger I, et al. Role of thrombophilic gene polymorphisms in branch retinal vein occlusion. Ophthalmology. 2005;112:1910–5.

    Article  PubMed  Google Scholar 

  22. Nguyen QD, Do DV, Feke GT, et al. Heparin-induced antiheparin-platelet antibody associated with retinal venous thrombosis. Ophthalmology. 2003;110: 600–3.

    Article  PubMed  Google Scholar 

  23. Browning DJ, Fraser CM. Retinal vein occlusions in patients taking warfarin. Ophthalmology. 2004;111:1196–2000.

    Article  PubMed  Google Scholar 

  24. Mruthyunjaya P, Wirostko WJ, Chandrashekhar R, et al. Central retinal vein occlusion in patients treated with long-term warfarin sodium (Coumadin) for anticoagulation. Retina. 2006;26:285–91.

    Article  PubMed  Google Scholar 

  25. Koizumi H, Ferrara DC, Brue C, Spaide RF. Central retinal vein occlusion case-control study. Am J Ophthalmol. 2007;144:858–63.

    Article  PubMed  Google Scholar 

  26. Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc. 1981;79:371–422.

    PubMed  CAS  Google Scholar 

  27. Chen HC, Wiek J, Gupta A, et al. Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion. Br J Ophthalmol. 1998;82:162–7.

    Article  PubMed  CAS  Google Scholar 

  28. Whittaker S, Winton F. The apparent viscosity of blood flowing in the isolated hindlimb of the dog, and its variations with corpuscular concentration. J Physiol. 1933;78:339–69.

    PubMed  CAS  Google Scholar 

  29. Hansen LL, Wiek J, Widerholt M. A randomised prospective study of treatment on non-ischemic central retinal vein occlusion by isovolemic hemodilution. Br J Ophthalmol. 1989;73:895–9.

    Article  PubMed  CAS  Google Scholar 

  30. Ring CP, Pearson TC, Sanders MD, et al. Viscosity and retinal vein thrombosis. Br J Ophthalmol. 1976;60:397–410.

    Article  PubMed  CAS  Google Scholar 

  31. Glacet-Bernard A, Chabanel A, Lelong F, et al. Elevated erythrocyte aggregation in patients with central retinal vein occlusion and without conventional risk factors. Ophthalmology. 1994;101: 1483–7.

    PubMed  CAS  Google Scholar 

  32. Hansen LL, Danisevskis P, Arntz HR, et al. A randomized prospective study on treatment of central retinal vein occlusion by isovolaemic haemodilution and photocoagulation. Br J Ophthalmol. 1985;69:108–16.

    Article  PubMed  CAS  Google Scholar 

  33. Hayreh SS. Retinal vein occlusion. Indian J Ophthalmol. 1994;42:109–32.

    PubMed  CAS  Google Scholar 

  34. Frucht J, Shapiro A, Merin S. Intraocluar pressure in retinal vein occlusion. Br J Ophthalmol. 1984;68:26–8.

    Article  PubMed  CAS  Google Scholar 

  35. Bills A. The uveal venous pressure. Arch Ophthalmol. 1963;69:780–2.

    Article  Google Scholar 

  36. Friedman E. The pathogenesis of age-related macular degeneration. Am J Ophthalmol. 2008;146:348–9.

    Article  PubMed  Google Scholar 

  37. Blumenthal M, Best M, Galvin MA, Gittinger JW. Ocular circulation: an analysis of the effect of induced ocular hypertension on retinal and choroidal blood flow in man. Am J Ophthalmol. 1971;71:819–25.

    PubMed  CAS  Google Scholar 

  38. Sinclair SH, Grunwald JE, Riva CE, et al. Retinal vascular autoregulation in diabetes mellitus. Ophthalmology. 1982;89:748–50.

    PubMed  CAS  Google Scholar 

  39. Harris A, Cuilla TA, Chung HK, Martin B. Regulation of retinal and optic nerve blood flow. Arch Ophthalmol. 1998;116:1491–5.

    PubMed  CAS  Google Scholar 

  40. Lund-Andersen H. Mechanisms for monitoring changes in retinal status following therapeutic intervention in diabetic retinopathy. Surv Ophthalmol. 2002;47:S270–7.

    Article  PubMed  Google Scholar 

  41. Hofman P, van Blijswijk BC, Gaillard PJ, et al. Endothelial cell hypertrophy induced by vascular endothelial growth factor in the retina. Arch Ophthalmol. 2001;119:861–6.

    Article  PubMed  CAS  Google Scholar 

  42. Menke MN, Feke GT, McMeel JW, et al. Hyperviscosity-related retinopathy in Waldenstrom macroglobulinemia. Arch Ophthalmol. 2006;124:1601–6.

    Article  PubMed  Google Scholar 

  43. Wu L, Arevalo JF, Berrocal MH, et al. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the Pan American Collaborative Retina Study Group at 24 months. Retina. 2010;30:1002–11.

    Article  PubMed  Google Scholar 

  44. Behrman S. Retinal vein obstruction. Br J Ophthalmol. 1962;46:336–42.

    Article  PubMed  CAS  Google Scholar 

  45. Yao Y, Ma Z, Zhao J. Luminal characteristics of the central retinal vessels in the anterior optic nerve of the young human. Retina. 2002;22:449–54.

    Article  PubMed  Google Scholar 

  46. Meyer-Schwickerath W, Kleinwachter T, Firsching R, Papenfub H. Central retinal venous outflow pressure. Graefes Arch Clin Exp Ophthalmol. 1995;783:788.

    Google Scholar 

  47. Stefansson E, Novack RL, Hatchell DL. Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci. 1990;31:284–9.

    PubMed  CAS  Google Scholar 

  48. Jonas JB. Ophthalmodynamometric assessment of the central retinal vein collapse pressure in eyes with central retinal vein stasis or occlusion. Graefes Arch Clin Exp Ophthalmol. 2003;241:367–70.

    Article  PubMed  Google Scholar 

  49. Gupta V, Sony P, Sihota R. Bilateral retinal venous occlusion in pigmentary glaucoma. Graefes Arch Clin Exp Ophthalmol. 2005;243:731–3.

    Article  PubMed  Google Scholar 

  50. Williamson TH, Baxter GM. Central retinal vein occlusion, an investigation by color doppler imaging. Ophthalmology. 1994;101:1362–72.

    PubMed  CAS  Google Scholar 

  51. Yoshida A, Feke GT, Mori F, et al. Reproducibility and clinical application of a newly developed stabilized retinal laser Doppler instrument. Am J Ophthalmol. 2003;135(3):356–61.

    Article  PubMed  Google Scholar 

  52. Arsene S, Giraudeau B, Lez MLL, et al. Follow up by color Doppler Imaging of 102 patients with retinal vein occlusion over 1 year. Br J Ophthalmol. 2010;86:1243–7.

    Article  Google Scholar 

  53. Arvas S, Ocakoglu O, Ozkan S. The capillary blood flow in ischaemic type central retinal vein occlusion: the effect of laser photocoagulation. Acta Ophthalmol Scand. 2002;80:490–4.

    Article  PubMed  Google Scholar 

  54. Hayreh SS. t-PA in CRVO. Ophthalmology. 2002;109:1758–60.

    Article  PubMed  Google Scholar 

  55. Hayreh SS. Occlusion of the central retinal vessels. Br J Ophthalmol. 1965;49:626–45.

    Article  PubMed  CAS  Google Scholar 

  56. Hayreh SS. Classification of central retinal vein occlusion. Ophthalmology. 1983;90:458–74.

    PubMed  CAS  Google Scholar 

  57. Mcleod D. Cilio-retinal arterial circulation in central retinal vein occlusion. Br J Ophthalmol. 1975;59:486–92.

    Article  PubMed  CAS  Google Scholar 

  58. Horio N, Horiguchi M. Retinal blood flow analysis using intraoperative video fluorescein angiography combined with optical fiber-free intravitreal surgery system. Am J Ophthalmol. 2004;138:1082–3.

    Article  PubMed  Google Scholar 

  59. Avila CP, Bartsch DU, Bitner DG, et al. Retinal blood flow measurements in branch retinal vein occlusion using scanning laser Doppler flowmetry. Am J Ophthalmol. 1998;126:683–90.

    Article  PubMed  Google Scholar 

  60. Pournaras CJ. Retinal oxygen distribution-its role in the physiopathology of vasoproliferative microangiopathies. Retina. 1995;15:332–47.

    Article  PubMed  CAS  Google Scholar 

  61. Linsenmeier RA, Padnick-Silver L. Metabolic dependence of photoreceptors on the choroid in the normal and detached retina. Invest Ophthalmol Vis Sci. 2000;41:3117–23.

    PubMed  CAS  Google Scholar 

  62. Stefansson E. Ocular oxygenation and the treatment of diabetic retinopathy. Surv Ophthalmol. 2006;51:364–80.

    Article  PubMed  Google Scholar 

  63. Feke GT, Tagawa H, Deupree DM, et al. Blood flow in the normal human retina. Invest Ophthalmol Vis Sci. 1989;30:58–65.

    PubMed  CAS  Google Scholar 

  64. Yoneya S, Saito T, Nishiyama Y, et al. Retinal oxygen saturation levels in patients with central retinal vein occlusion. Ophthalmology. 2002;109:1521–6.

    Article  PubMed  Google Scholar 

  65. Mcleod D. Central retinal vein obstruction with cilio-retinal infarction. Eye. 2003;17:283.

    Article  PubMed  CAS  Google Scholar 

  66. Schweitzer D, Hammer M, Kraft J, et al. In vivo measurement of the oxygen saturation in retinal vessels in healthy volunteers. IEEE Trans Biomed Eng. 1999;46:1454–65.

    Article  PubMed  CAS  Google Scholar 

  67. Hardarson SH, Stefansson E. Oxygen saturation in central retinal vein occlusion. Am J Ophthalmol. 2010;150:871–5.

    Article  PubMed  Google Scholar 

  68. Pournaras CJ, Miller JW, Gragoudas ES, et al. Systemic hyperoxia decreases vascular endothelial growth factor gene expression in ischemic primate retina. Arch Ophthalmol. 1997;115:1553–8.

    Article  PubMed  CAS  Google Scholar 

  69. Stefansson E, Landers III MB, Wolbarsht ML. Vitrectomy, lensectomy, and ocular oxygenation. Retina. 1982;2:159–66.

    Article  PubMed  CAS  Google Scholar 

  70. Pournaras CJ, Tsacopoulos M, Strommer K, et al. Experimental retinal branch vein occlusion in miniature pigs induces local tissue hypoxia and vasoproliferative microangiopathy. Ophthalmology. 1990;97:1321–8.

    PubMed  CAS  Google Scholar 

  71. Schonfelder U, Hofer A, Paul M, Funk RH. In situ observation of living pericytes in rat retinal capillaries. Microvasc Res. 1998;56:22–9.

    Article  PubMed  CAS  Google Scholar 

  72. Brown SM, Jampol LM. New concepts of regulation of retinal vessel tone. Arch Ophthalmol. 1996;114:199–204.

    Article  PubMed  CAS  Google Scholar 

  73. Mendrinos E, Mangioris G, Papadopoulou DN, et al. Retinal vessel analyzer measurements of the effect of panretinal photocoagulation on the reinal arteriolar diameter in diabetic retinopathy. Retina. 2010;30:555–61.

    Article  PubMed  Google Scholar 

  74. Harris A, Jonescu-Cuypers CP, Kagemann L, et al. Atlas of ocular blood flow: vascular anatomy, pathophysiology, and metabolism. Philadelphia: Butterworth Heinemann; 2003. p. 1–128.

    Google Scholar 

  75. Cioffi GA, Wang L, Fortune B, et al. Chronic ischemia induces regional axonal damage in experimental primate optic neuropathy. Arch Ophthalmol. 2004;122:1517–25.

    Article  PubMed  Google Scholar 

  76. Chen Q, Anderson DR. Effect of CO2 on intracellular pH and contraction of retinal capillary pericytes. Invest Ophthalmol Vis Sci. 1997;38:643–51.

    PubMed  CAS  Google Scholar 

  77. Klein BEK, Klein R, Myers CE, Lee KE. Complete blood cell count and retinal vessel diameters. Arch Ophthalmol. 2011;129:490–7.

    Article  PubMed  Google Scholar 

  78. Nagaoka T, Yoshida A. The effect of ocular warming on ocular circulation in healthy humans. Arch Ophthalmol. 2004;122:1477–81.

    Article  PubMed  Google Scholar 

  79. Clermont AC, Aiello LP, Mori F, et al. Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. Am J Ophthalmol. 1997;124:433–46.

    PubMed  CAS  Google Scholar 

  80. Quiram P, Lai M, Trese M. Surgical management of retinopathy of prematurity. In: Joussen AM, Gardner TW, Kirchhof B, Ryan SJ, editors. Retinal vascular disease. Berlin/Heidelberg: Springer; 2007; Chap. 20.3.

    Google Scholar 

  81. Hayreh SS. Posterior ciliary artery circulation in health and disease. The Weisenfeld Lecture. Invest Ophthalmol Vis Sci. 2004;45:749–57.

    Article  PubMed  Google Scholar 

  82. McLeod D. Krogh cylinders in retinal development, panretinal hypoperfusion and diabetic retinopathy. Acta Ophthalmol. 2010;88:817–35.

    Article  PubMed  Google Scholar 

  83. Mcleod D. Why cotton wool spots should not be regarded as retinal nerve fiber layer infarcts. Br J Ophthalmol. 2005;89:229–37.

    Article  PubMed  CAS  Google Scholar 

  84. Iwasaki M, Inomata H. Relation between superficial capillaries and foveal structures in the human retina. Invest Ophthalmol Vis Sci. 1986;27:1698–705.

    PubMed  CAS  Google Scholar 

  85. Riva C, Petrig B. Blue field entoptic phenomenon and blood velocity in the retinal capillaries. Opt Soc Am. 1980;70(10):1234–8.

    Article  CAS  Google Scholar 

  86. Moore J, Bagley S, Ireland G, et al. Three dimensional analysis of microaneurysms in the human diabetic retina. J Anat. 1999;194:89–100.

    Article  PubMed  Google Scholar 

  87. Bringmann A, Uckermann O, Pannicke T, et al. Neuronal versus glial cell swelling in the ischemic retina. Acta Ophthalmol Scand. 2005;83:528–38.

    Article  PubMed  Google Scholar 

  88. Distler C, Dreher Z. Glia cells in the monkey retina-II. Muller cells. Vision Res. 1996;36:2381–94.

    Article  PubMed  CAS  Google Scholar 

  89. Stewart RMK, Clearkin LG. Insulin resistance and autoregulatory dysfunction in glaucoma and retinal vein occlusion. Am J Ophthalmol. 2008;145:394–6.

    Article  PubMed  CAS  Google Scholar 

  90. Antcliff RJ, Hussain AA, Marshall J. Hydraulic conductivity of fixed retinal tissue after sequential excimer laser ablation-Barriers limiting fluid distribution and implications for cystoid macular edema. Arch Ophthalmol. 2001;119:539–44.

    Article  PubMed  CAS  Google Scholar 

  91. Gupta B, Grewal J, Adewoyin T, et al. Diurnal variation of macular edema in CRVO: prospective study. Graefes Arch Clin Exp Ophthalmol. 2009;247:593–6.

    Article  PubMed  CAS  Google Scholar 

  92. Quintyn JC, Brasseur G. Subretinal fluid in primary rhegmatogenous retinal detachment: physiopathology and composition. Surv Ophthalmol. 2004;49:96–108.

    Article  PubMed  Google Scholar 

  93. La Cour M. The retinal pigment epithelium. In: Kaufman PL, editor. Adler’s physiology of the eye clinical application. 10th ed. St. Louis: Mosby; 2003.

    Google Scholar 

  94. Sander B, Larsen M, Lund-Andersen H. Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier. Invest Ophthalmol Vis Sci. 2001;42:433–8.

    PubMed  CAS  Google Scholar 

  95. Reichenbach A, Wurm A, Pannicke T, et al. Muller cells as players in retinal degeneration and edema. Graefes Arch Clin Exp Ophthalmol. 2007;245:627–36.

    Article  PubMed  Google Scholar 

  96. Luan H, Roberts R, Sniegowski M, et al. Retinal thickness and subnormal retinal oxygenation response in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci. 2006;47:320–8.

    Article  PubMed  Google Scholar 

  97. Ng EW, Adamis AP. Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. Can J Ophthalmol. 2005;40:352–68.

    PubMed  Google Scholar 

  98. Glaser BM. Extracellular modulating factors and the control of intraocular neovascularization. Arch Ophthalmol. 1988;106:603–7.

    Article  PubMed  CAS  Google Scholar 

  99. Schlingemann RO, van Hinsbergh VWM. Role of vascular permeability factor/vascular endothelial growth factor in eye disease. Br J Ophthalmol. 1997;81:501–12.

    Article  PubMed  CAS  Google Scholar 

  100. Lutty G, McLeod S, Merges C, et al. Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol. 1996;114:971–7.

    Article  PubMed  CAS  Google Scholar 

  101. Tolentino MJ, Miller JW, Gragoudas ES, et al. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. Arch Ophthalmol. 1996;114:964–70.

    Article  PubMed  CAS  Google Scholar 

  102. Houck KA, Leung DW, Rowland AM, et al. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem. 1992;267:26031–7.

    PubMed  CAS  Google Scholar 

  103. Nishijima K, Ng YS, Zhong L, et al. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol. 2007;171:53–67.

    Article  PubMed  CAS  Google Scholar 

  104. Ehlken C, Rennel ES, Michels D, et al. Levels of VEGF but not VEGF 165b are increased in the vitreous of patients with retinal vein occlusion. Am J Ophthalmol. 2011;152:298–303.

    Article  PubMed  CAS  Google Scholar 

  105. Shima DT, Gougos A, Miller JW, et al. Cloning and mRNA Expression of vascular endothelial growth factor in ischemic retinas of macaca fascicularis. Invest Ophthalmol Vis Sci. 1996;37:1334–40.

    PubMed  CAS  Google Scholar 

  106. Tischer E, Mitchell R, Hartman T, et al. The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing. J Biol Chem. 1991;266:11947–54.

    PubMed  CAS  Google Scholar 

  107. Noma H, Funatsu H, Sakata K, et al. Macular microcirculation and macular edema in branch retinal vein occlusion. Br J Ophthalmol. 2009;93:630–3.

    Article  PubMed  CAS  Google Scholar 

  108. Cohen T, Nahari D, Cerem LW, et al. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem. 1996;271:736–41.

    Article  PubMed  CAS  Google Scholar 

  109. Behzadian MA, Wang XL, Al-Shabrawey M, Caldwell RB. Effects of hypoxia on glial cell expression of angiogenesis-regulating factors VEGF and TGF-beta. Glia. 1998;24:216–25.

    Article  PubMed  CAS  Google Scholar 

  110. Aiello LP, Arrigg PG, Keyt BA, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480–7.

    Article  PubMed  CAS  Google Scholar 

  111. Miller JW, Adamis AP, Shima DT, et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol. 1994;145:574–84.

    PubMed  CAS  Google Scholar 

  112. Pe’er J, Folberg R, Itin A, et al. Vascular endothelial growth factor upregulation in human central retinal vein occlusion. Ophthalmology. 1998;105:412–6.

    Article  PubMed  Google Scholar 

  113. Dorey CK, Aouididi S, Reynaud X, et al. Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovascularization in the rat. Arch Ophthalmol. 1996;114:1210–7.

    Article  PubMed  CAS  Google Scholar 

  114. Boyd SR, Zachary I, Chakravarthy U, et al. Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion. Arch Ophthalmol. 2002;120:1644–50.

    Article  PubMed  CAS  Google Scholar 

  115. Aiello LP. Vascular endothelial growth factor and the eye-past, present, and future. Arch Ophthalmol. 1996;114:1252–4.

    Article  PubMed  CAS  Google Scholar 

  116. Spoerri PE, Afzal A, Calzi SL, et al. Effects of VEGFR-1, VEGFR-2, and IGF-IR hammerhead ribozymes on glucose-mediated tight junction expression in cultured human retinal endothelial cells. Mol Vis. 2006;12:32–42.

    PubMed  CAS  Google Scholar 

  117. Miyake K, Miyake T, Kayazawa F. Blood-aqueous barrier in eyes with retinal vein occlusion. Ophthalmology. 1992;99:906–10.

    PubMed  CAS  Google Scholar 

  118. Adamis AP, Shima DT, Tolentino MJ, et al. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol. 1996;114:66–71.

    Article  PubMed  CAS  Google Scholar 

  119. Joussen AM, Poulaki V, Qin W, et al. Retinal vascular endothelial growth factor induces intercellular adhesion molecule −1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am J Pathol. 2002;160:501–9.

    Article  PubMed  CAS  Google Scholar 

  120. Radisavljevic Z, Avraham H, Avraham S. Vascular endothelial growth factor up-regulates ICAM-1 expression via the phosphatidylinositol 3 OH-kinase/AKT/Nitric oxide pathway and modulates migration of brain microvascular endothelial cells. J Biol Chem. 2000;275:20770–4.

    Article  PubMed  CAS  Google Scholar 

  121. Lu M, Perez VL, Ma N, et al. VEGF increases retinal vascular ICAM-1 expression in vivo. Invest Ophthalmol Vis Sci. 1999;40:1808–12.

    PubMed  CAS  Google Scholar 

  122. Noma H, Funatsu H, Mimura T, et al. Pigment epithelium-derived factor and vascular endothelial growth factor in branch retinal vein occlusion with macular edema. Graefes Arch Clin Exp Ophthalmol. 2010;248(11):1559–65.

    Article  PubMed  CAS  Google Scholar 

  123. Mechtcheriakova D, Wlachos A, Holzmuller H, et al. Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1. Blood. 1999;93:3811–23.

    PubMed  CAS  Google Scholar 

  124. Ikeda E, Achen MG, Breier G, Risau W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem. 1995;270:19761–6.

    Article  PubMed  CAS  Google Scholar 

  125. Safran M, Kaelin Jr WG. HIF hydroxylation and the mammalian oxygen-sensing pathway. J Clin Invest. 2003;111:779–83.

    PubMed  CAS  Google Scholar 

  126. Alon T, Hemo I, Itin A, et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med. 1995;1(10):1024–8.

    Article  PubMed  CAS  Google Scholar 

  127. Terui T, Kondo M, Sugita T, et al. Changes in areas of capillary nonperfusion after intravitreal injection of bevacizumab in eyes with branch retinal vein occlusion. Retina. 2011;31:1068–74.

    Article  PubMed  CAS  Google Scholar 

  128. Luna JD, Chan CC, Derevjanik NL, et al. Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown. J Neurosci Res. 1997;49(3):268–80.

    Article  PubMed  CAS  Google Scholar 

  129. Noma H, Funatsu H, Mimura T, Shimada K. Increase of aqueous inflammatory factors in macular edema with branch retinal vein occlusion: a case-control study. J Inflamm. 2010;7:44.

    Article  CAS  Google Scholar 

  130. Noma H, Funatsu H, Mimura T, et al. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Ophthalmology. 2009;116:87–93.

    Article  PubMed  Google Scholar 

  131. Maruo N, Morita I, Shirao M, Murota S. IL-6 increases endothelial permeability in vitro. Endocrinology. 1992;131:710–4.

    Article  PubMed  CAS  Google Scholar 

  132. Yoshida A, Yoshida S, Khalil AK, et al. Role of NF-kB-mediated interleukin-8 expression in intraocular neovascularization. Invest Ophthalmol Vis Sci. 1998;39:1097–106.

    PubMed  CAS  Google Scholar 

  133. Fonollosa A, Garcia-Arumi J, Santos E, et al. Vitreous levels of interleukin-8 and monocyte chemoattractant protein-1 in macular edema with branch retinal vein occlusion. Eye. 2010;24:1284–90.

    Article  PubMed  CAS  Google Scholar 

  134. Carr MW, Roth SJ, Luther E, et al. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA. 1994;91:3652–6.

    Article  PubMed  CAS  Google Scholar 

  135. Xu LL, Warren MK, Rose WL, et al. Human recombinant monocyte chemotactic protein and other c-c chemokines bind and induce directional migration of dendritic cells in vitro. J Leukoc Biol. 1996;60:365–71.

    PubMed  CAS  Google Scholar 

  136. Yoshimura T, Sonoda KH, Sugahara M, et al. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS One. 2009;4:E8158.

    Article  PubMed  CAS  Google Scholar 

  137. Stahl A, Buchwald A, Martin G, et al. Vitreal levels of erythropoietin are increased in patients with retinal vein occlusion and correlate with vitreal VEGF and the extent of macular edema. Retina. 2010;30:1524–9.

    Article  PubMed  Google Scholar 

  138. Inomata Y, Hirata A, Takahashi E, et al. Elevated erythropoietin in vitreous with ischemic retinal diseases. Neuroreport. 2004;15(5):877–9.

    Article  PubMed  CAS  Google Scholar 

  139. Garci-Arumi J, Fonollosa A, Macia C, et al. Vitreous levels of erythropoietin in patients with macular oedema secondary to retinal vein occlusions: a comparative study with diabetic macular oedema. Eye. 2009;23:1066–71.

    Article  PubMed  CAS  Google Scholar 

  140. Chen J, Connor KM, Aderman CM, Smith LEH. Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest. 2008;118(2):526–33.

    PubMed  CAS  Google Scholar 

  141. De Juan E, Stefansson E, Ohira A. Basic fibroblast growth factor stimulates 3H-thymidine uptake in retinal venular and capillary endothelial cells in vivo. Invest Ophthalmol Vis Sci. 1990;31:1238–44.

    PubMed  Google Scholar 

  142. Neely KA, Gardner TW. Commentary: ocular neovascularization, clarifying complex interactions. Am J Pathol. 1998;153:665–70.

    Article  PubMed  CAS  Google Scholar 

  143. Noma H, Funatsu H, Sakata K, et al. Association between macular microcirculation and soluble intercellular adhesion molecule-1 in patients with macular edema and retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2010;248(10):1515–8.

    Article  PubMed  CAS  Google Scholar 

  144. Ates O, Keles M, Bilen H, et al. Increased serum levels of leptin in retinal vein occlusion. Tohoku J Exp Med. 2008;215:373–6.

    Article  PubMed  CAS  Google Scholar 

  145. Gariano RF, Nath AK, D’Amico DJ, et al. Elevation of vitreous leptin in diabetic retinopathy and retinal detachment. Invest Ophthalmol Vis Sci. 2000;41:3576–81.

    PubMed  CAS  Google Scholar 

  146. Okunuki Y, Usui Y, Katai N, et al. Relation of intraocular concentrations of inflammatory factors and improvement of macular edema after vitrectomy in branch retinal vein occlusion. Am J Ophthalmol. 2011;151:610–6.

    Article  PubMed  Google Scholar 

  147. Park DH, Kim IT. Long-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusion. Retina. 2010;30:117–24.

    Article  PubMed  Google Scholar 

  148. Noma H, Minamoto A, Funatsu H, et al. Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2006;244:309–15.

    Article  PubMed  CAS  Google Scholar 

  149. Noma H, Funatsu H, Yamasaki M, et al. Aqueous humor levels of cytokines are correlated to vitreous levels and severity of macular edema in branch retinal vein occlusion. Eye. 2008;22:42–8.

    Article  PubMed  CAS  Google Scholar 

  150. Park SP, Ahn JK, Mun GH. Aqueous vascular endothelial growth factor levels are associated with serous macular detachment secondary to branch retinal vein occlusion. Retina. 2010;30:281–6.

    Article  PubMed  Google Scholar 

  151. Shimura M, Nakazawa T, Yasuda K, Kunikata H, Shiono T, Nishida K. Visual prognosis and vitreous cytokine levels after arteriovenous sheathotomy in branch retinal vein occlusion associated with macular oedema. Acta Ophthalmol. 2008;86(4):377–84.

    Article  PubMed  CAS  Google Scholar 

  152. Noma H, Funatsu H, Yamasaki M, et al. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol. 2005;140:256–61.

    Article  PubMed  CAS  Google Scholar 

  153. Noma H, Funatsu H, Sakata K, et al. Macular microcirculation in hypertensive patients with and without branch retinal vein occlusion. Acta Ophthalmol. 2009;87(6):638–42.

    Article  PubMed  Google Scholar 

  154. Campochiaro PA, Hafiz G, Channa R, et al. Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes. Ophthalmology. 2010;117(12):2387–94.

    Article  PubMed  Google Scholar 

  155. Adrean SD, Schwab IR. Central retinal vein occlusion and renal cell carcinoma. Am J Ophthalmol. 2003;136:1185–6.

    Article  PubMed  Google Scholar 

  156. Funk M, Kriechbaum K, Prager F, et al. Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab. Invest Ophthalmol Vis Sci. 2009;50:1025–32.

    Article  PubMed  Google Scholar 

  157. Noma H, Funatsu H, Mimura T, et al. Role of soluble vascular endothelial growth factor receptor-2 in macular oedema with central retinal vein occlusion. Br J Ophthalmol. 2011;95:788–92.

    Article  PubMed  Google Scholar 

  158. He H, Venema VJ, Gu X, et al. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through Flk-1/KDR activation of c-Src. J Biol Chem. 1999;274:25130–5.

    Article  PubMed  CAS  Google Scholar 

  159. Zweier JL, Kuppusamy P, Lutty GA. Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues. Proc Natl Acad Sci USA. 1988;85:4046–50.

    Article  PubMed  CAS  Google Scholar 

  160. Chan CC, Little HL. Infrequency of retinal neovascularization following central retinal vein occlusion. Ophthalmology. 1979;86(2):256–63.

    PubMed  CAS  Google Scholar 

  161. Magargal LE, Donoso LA, Sanborn GE. Retinal ischemia and risk of neovascularization following central retinal vein obstruction. Ophthalmology. 1982;89:1241–5.

    PubMed  CAS  Google Scholar 

  162. Hikichi T, Konno S, Trempe CL. Role of the vitreous in central retinal vein occlusion. Retina. 1995;15:29–33.

    PubMed  CAS  Google Scholar 

  163. Kado M, Trempe CL. Role of the vitreous in branch retinal vein occlusion. Am J Ophthalmol. 1988; 105(1):20–4.

    PubMed  CAS  Google Scholar 

  164. Balaratnasingam C, Morgan WH, Hazelton ML, et al. Value of retinal vein pulsation characteristics in predicting increased optic disc excavation. Br J Ophthalmol. 2007;91:441–4.

    Article  PubMed  Google Scholar 

  165. Fong ACO, Schatz H. Central retinal vein occlusion in young adults. Surv Ophthalmol. 1993;37:393–417.

    Article  PubMed  CAS  Google Scholar 

  166. Mcleod D, Ring CP. Cilio-retinal infarction after retinal vein occlusion. Br J Ophthalmol. 1976;60:419–27.

    Article  Google Scholar 

  167. Hayreh SS, Fraterrigo L, Jonas J. Central retinal vein occlusion associated with cilioretinal artery occlusion. Retina. 2008;28:581–94.

    Article  PubMed  Google Scholar 

  168. Schatz H, Fong ACO, McDonald HR, et al. Cilioretinal artery occlusion in young adults with central retinal vein occlusion. Ophthalmology. 1991;98:594–601.

    PubMed  CAS  Google Scholar 

  169. Keyser BJ, Duker JS, Brown GC, et al. Combined central retinal vein occlusion and cilioretinal artery occlusion associated with prolonged retinal arterial filling. Am J Ophthalmol. 1994;117:308–13.

    PubMed  CAS  Google Scholar 

  170. Jacks AS, Miller NR. Spontaneous retinal venous pulsation: aetiology and significance. J Neuro Neurosurg Psychiatry. 2003;74:7–9.

    Article  CAS  Google Scholar 

  171. Donati G, Kapetanios AD, Pournaras CJ. NO donors and experimental retinal vein occlusion. J Fr Ophthalmol. 1999;22:446–50.

    CAS  Google Scholar 

  172. Lee YJ, Kim JH, Ko MK. Neovascularization in branch retinal vein occlusion combined with arterial insufficiency. Korean J Ophthalmol. 2005;19:34–9.

    Article  PubMed  Google Scholar 

  173. Hamilton AM, Kohner EM, Rosen D, et al. Experimental retinal branch vein occlusion in rhesus monkeys. I. Clinical appearances. Br J Ophthalmol. 1979;63:377–87.

    Article  PubMed  CAS  Google Scholar 

  174. Zhang H, Sonoda KH, Qiao H, et al. Development of a new mouse model of branch retinal vein occlusion and retinal neovascularization. Jpn J Ophthalmol. 2007;51(4):251–7.

    Article  PubMed  Google Scholar 

  175. Tameesh MK, Lakhanpal RR, Fujii GY, et al. Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs. Am J Ophthalmol. 2004;138:829–39.

    Article  PubMed  CAS  Google Scholar 

  176. Tolentino MJ, Miller JW, Gragoudas ES, et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology. 1996;103:1820–8.

    PubMed  CAS  Google Scholar 

  177. Danis RP, Yang Y, Massicotte SJ, Boldt C. Preretinal and optic nerve head neovascularization induced by photodynamic venous thrombosis in domestic pigs. Arch Ophthalmol. 1993;111:539–43.

    Article  PubMed  CAS  Google Scholar 

  178. Rosen DA, Marshall J, Kohner EM, et al. Experimental retinal branch vein occlusion in rhesus monkeys. II. Retinal blood flow studies. Br J Ophthalmol. 1979;63:388–92.

    Article  PubMed  CAS  Google Scholar 

  179. Wallow I, Danis R, Bindley C, Neider M. Cystoid macular degeneration in experimental BRVO. Ophthalmology. 1988;95:1371–9.

    PubMed  CAS  Google Scholar 

  180. Hockley DJ, Tripathi RC, Ashton N. Experimental retinal branch vein occlusion in rhesus monkeys. III. Histopathological and electron microscopical studies. Br J Ophthalmol. 1979;63:393–411.

    Article  PubMed  CAS  Google Scholar 

  181. Kube T, Feltgen N, Pache M, et al. Angiographic findings in arteriovenous dissection (sheathotomy) for decompression of branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2005;243(4):334–8.

    Article  PubMed  Google Scholar 

  182. Ameri H, Ratanapakorn T, Rao NA, et al. Natural course of experimental retinal vein occlusion in rabbit; arterial occlusion following venous photothrombosis. Graefes Arch Clin Exp Ophthalmol. 2008;246:1429–39.

    Article  PubMed  Google Scholar 

  183. Royster AJ, Nanda SK, Hatchell DL, et al. Photochemical initiation of thrombosis: fluorescein angiographic, histologic, and ultrastructural alterations in the choroid, retinal pigment epithelium, and retina. Arch Ophthalmol. 1988;106:1608–14.

    Article  PubMed  CAS  Google Scholar 

  184. Nanda S, Hatchell D, Tiedeman J, et al. A new method for vascular occlusion. Arch Ophthalmol. 1987;105:1121–4.

    Article  PubMed  CAS  Google Scholar 

  185. Ameri H, Kim JG, Ratanapakorn T, et al. Intravitreal and subretinal injection of tissue plasminogen activator (tPA) in the treatment of experimentally created retinal vein occlusion in rabbits. Retina. 2008;28:350–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Charlotte Eye Ear Nose & Throat Associates, Charlotte, North Carolina, USA

    David J. Browning MD, PhD

Authors
  1. David J. Browning MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media New York

About this chapter

Cite this chapter

Browning, D.J. (2012). Pathophysiology of Retinal Vein Occlusions. In: Retinal Vein Occlusions. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3439-9_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-3439-9_2

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-3438-2

  • Online ISBN: 978-1-4614-3439-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation